|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 239.28 USD | -1.01% |
|
+4.38% | +12.21% |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 14.78B | |||||
| 45.62B | |||||
| 34.34B | |||||
| 29.46B | |||||
| 28.09B | |||||
| 19.11B | - | - | - | - | - |
- Stock Market
- Equities
- ASND Stock
- Charts Ascendis Pharma A/S
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
